articleCirculationAug 26, 2013Closed access

Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

Auckland City Hospital

Indexed incrossref

Abstract

Background— The most frequent complications associated with implantable cardioverter-defibrillators (ICDs) involve the transvenous leads. A subcutaneous implantable cardioverter-defibrillator (S-ICD) has been developed as an alternative system. This study evaluated the safety and effectiveness of the S-ICD System (Cameron Health/Boston Scientific) for the treatment of life-threatening ventricular arrhythmias (ventricular tachycardia/ventricular fibrillation). Methods and Results— This prospective, nonrandomized, multicenter trial included adult patients with a standard indication for an ICD, who neither required pacing nor had documented pace-terminable ventricular tachycardia. The primary safety end point was…

Citation impact

551
total citations
FWCI
32.49
Percentile
100%
References
31
Citations per year

Authors

12

Topics & keywords

Keywords
  • Medicine
  • Ventricular fibrillation
  • Ventricular tachycardia
  • Cardiology
  • Implantable cardioverter-defibrillator
  • Clinical endpoint
  • Internal medicine
  • Cohort
No related works found for this paper.